Expect Aggressive Life Sciences Enforcement In 2022

By Joshua Oyster, Beth Weinman and Lauren Sager · February 14, 2022, 5:56 PM EST

Pharmaceutical and medical device companies and their executives should prepare for a wild ride in 2022, as we are likely to see an increasingly aggressive and emboldened U.S. Department of Justice....

To view the full article, register now.